NCT00818324View on ClinicalTrials.gov

Long Term Administration Study of OPC-12759 Ophthalmic Suspension

PHASE3CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

January 31, 2011

Conditions
Dry Eye Syndromes
Interventions
DRUG

OPC-12759 Ophthalmic suspension

Instillation,4times/day,for 52weeks

Trial Locations (5)

Unknown

Kansai Region

Kanto Region

Kyushu Region

Tohoku Region

Tokai Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY